Cargando…

First person – Danny Legge

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Danny Legge is first author on ‘BCL-3 promotes a cancer stem cell phenotype by enhanc...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451424/
http://dx.doi.org/10.1242/dmm.039412
_version_ 1783409189809291264
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Danny Legge is first author on ‘BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells’, published in DMM. Danny conducted the research described in this article while a PhD student in Professor Ann Williams's lab at Colorectal Tumour Biology Group, School of Cellular and Molecular Medicine, University of Bristol, UK. He is now a postdoc in the lab of Dr Keith Brown at Cancer Epigenetics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, UK, investigating the role of cancer stem cells in colorectal cancer.
format Online
Article
Text
id pubmed-6451424
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-64514242019-04-08 First person – Danny Legge Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Danny Legge is first author on ‘BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells’, published in DMM. Danny conducted the research described in this article while a PhD student in Professor Ann Williams's lab at Colorectal Tumour Biology Group, School of Cellular and Molecular Medicine, University of Bristol, UK. He is now a postdoc in the lab of Dr Keith Brown at Cancer Epigenetics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, UK, investigating the role of cancer stem cells in colorectal cancer. The Company of Biologists Ltd 2019-03-01 2019-03-07 /pmc/articles/PMC6451424/ http://dx.doi.org/10.1242/dmm.039412 Text en © 2019. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/4.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Danny Legge
title First person – Danny Legge
title_full First person – Danny Legge
title_fullStr First person – Danny Legge
title_full_unstemmed First person – Danny Legge
title_short First person – Danny Legge
title_sort first person – danny legge
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451424/
http://dx.doi.org/10.1242/dmm.039412